-

U.S. Cannabis Market Trends Analysis Report 2025-2030 | Celebrity-Backed Brands from Celebrities Such as Jay-Z & Snoop, and Mainstream Companies Drive Growth Amid Expanding Legalization - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By Cultivation (Indoor Cultivation, Outdoor Cultivation) By End-use (Medical Use, Recreational Use), And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.

The U.S. cannabis market size is expected to reach USD 76.39 billion by 2030, registering a CAGR of 11.5% from 2025 to 2030

Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected to boost the market growth.

Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected to be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated to occur in the U.S. In addition to that, two cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.

Rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.

With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking to benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity's involvement in the cultivation process. Despite this scrutiny, more celebrities are expected to follow this trend and enter the cannabis cultivation industry.

New technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, which further drives the market growth.

U.S. Cannabis Market Report Highlights

  • The marijuana segment dominated the market with the highest revenue share of 87.7% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The hemp segment is anticipated to grow at a significant CAGR from 2025 to 2030.
  • The CBD segment dominated the market with the largest revenue share of 63.3% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health issues.
  • The indoor cultivation segment dominated the market with the largest revenue share of 54.8% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The outdoor cultivation segment held a significant share in 2024.
  • The recreational use segment dominated the market with a revenue share of 66.9% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. The medical use segment is anticipated to grow significantly over the forecast period.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2024 - 2030
Estimated Market Value (USD) in 2024 $38.5 Billion
Forecasted Market Value (USD) by 2030 $76.39 Billion
Compound Annual Growth Rate 11.5%
Regions Covered United States 

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Market Variables, Trends, and Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. U.S. Cannabis Market - Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.3. Business Environment Analysis Tools: U.S. Cannabis Market

3.3.1. Porter's Five Forces Analysis

3.3.2. PESTLE Analysis

3.4. Current Market Trends in Cannabis Industry

3.5. Regulatory Scenario

3.6. Licensing Scenario in the U.S.

3.7. Cannabis Consumption Pattern Analysis

3.8. Legal Cannabis Potential Trade Opportunity

3.9. Legal Cannabis Seed to Shelf Story

3.10. Supply Chain Analysis

3.11. Legal Cannabis Industry: U.S. Country Case Studies

3.12. Guidelines and Requirements for Cannabis Cultivation

3.13. Cannabis Facility Design and Equipment Requirements

3.14. Government Policy Designing Cannabis Guidelines

3.14.1. Federal Cannabis Policy

3.14.2. Policy Challenges and Opportunities

3.15. Reimbursement Policies in the U.S

3.16. Taxation Policies in The U.S.

Chapter 4. U.S. Cannabis Market: Source Estimates & Trend Analysis

4.1. Definition and Scope

4.2. Source Market Share Analysis, 2024 & 2030

4.3. Segment Dashboard

4.4. U.S. Cannabis Market, by Source, 2018 to 2030

4.5. Marijuana

4.6. Hemp

Chapter 5. U.S. Cannabis Market: Derivative Estimates & Trend Analysis

5.1. Definition and Scope

5.2. Derivative Market Share Analysis, 2024 & 2030

5.3. Segment Dashboard

5.4. U.S. Cannabis Market, by Derivative, 2018 to 2030

5.5. CBD

5.6. THC

5.7. Others

Chapter 6. U.S. Cannabis Market: Cultivation Estimates & Trend Analysis

6.1. Definition and Scope

6.2. Cultivation Market Share Analysis, 2024 & 2030

6.3. Segment Dashboard

6.4. U.S. Cannabis Market, by Cultivation, 2018 to 2030

6.5. Indoor Cultivation

6.6. Greenhouse Cultivation

6.7. Outdoor Cultivation

Chapter 7. U.S. Cannabis Market: End Use Estimates & Trend Analysis

7.1. Definition and Scope

7.2. End Use Market Share Analysis, 2024 & 2030

7.3. Segment Dashboard

7.4. U.S. Cannabis Market, by End Use, 2018 to 2030

7.5. Medical Use

7.6. Recreational Use

7.7. Industrial Use

Chapter 8. U.S. Cannabis Market: Competitive Landscape

8.1. Participant's Categorization

8.2. Company Market Position Analysis, 2024

8.3. Strategy Mapping

8.4. Company Profiles

8.4.1. Overview

8.4.2. Financial Performance

8.4.3. Product Benchmarking

8.4.4. Strategic Initiatives

  • Medical Marijuana, Inc.
  • NuLeaf Naturals, LLC
  • CV Sciences, Inc.
  • CHARLOTTE'S WEB.
  • The Cronos Group
  • Organigram Holding, Inc
  • Irwin Naturals
  • Tilray Brands
  • Canopy Growth Corporation
  • Aurora Cannabis

For more information about this report visit https://www.researchandmarkets.com/r/es2dbx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Europe Pyridine Market Forecast and Company Analysis Report 2025-2033 Featuring Lonza, Bayer, Jubilant Pharmova, Mitsubishi Chemical, Imperial Chemical, Nippon Steel & Sumikin Chemical, Koei - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Pyridine Market Size, Companies and Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Europe Pyridine Market was valued at USD 198.85 million in 2024 and is anticipated to expand to USD 288.21 million by 2033, growing at a CAGR of 4.21% from 2025 to 2033. This growth is due to growing demand from agrochemicals, pharmaceuticals, and food industries, as well as expanding applications in solvents, pesti...

Saudi Arabia Wine Market Forecast and Company Analysis Report 2025-2033 Featuring Accolade Wines, Alko, Allagash, Allied Blenders & Distillers, Arkell's, Anchor Brewing, Asahi, and Bass - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Saudi Arabia Wine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. Saudi Arabia Wine market is expected to reach US$ 7.90 billion by 2033 from US$ 4.60 billion in 2024, with a CAGR of 6.20% from 2025 to 2033 A number of factors are driving the market's growth, including rising consumer interest in non-alcoholic wine substitutes, an increasing number of expatriates, high-end din...

Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025 | Opportunity, Generic Availability, Drug Dosage, Price & Clinical Trials Insights to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Selective Estrogen Receptor Degrader (SERDs) Market Opportunity, Generic Availability, Drug Dosage, Price & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The SERD market, while narrow in terms of approved medicines, has developed with rapid evolving into a dynamic and competitive landscape. With deep pipelines, sophisticated trial programs, and new technologies such as PROTACs, SERDs are already set to revolutionize t...
Back to Newsroom